局部晚期宫颈癌放化疗中非意愿性体重下降与肿瘤结局
近80%患者出现体重下降,14%为严重体重下降;严重体重下降者死亡风险升高(HR=2.37,95%CI 1.77–7.37,p=0.036)。
要点
- 局部晚期宫颈癌同步放化疗中近80%出现体重下降,14%为严重下降。
- FIGO 2009 III–IV期患者严重体重下降风险是早期患者的3.4倍。
- 严重体重下降与死亡风险升高相关,复发风险呈升高趋势但未达统计学显著。
核心结论
- 非意愿性体重下降是局部晚期宫颈癌同步放化疗患者常见且未被充分识别的症状,与较差的肿瘤结局相关。
主要发现
- 近80%患者出现至少一定程度的体重下降,14%患者出现严重体重下降(较基线下降≥10%)。
- FIGO 2009 III或IV期患者严重体重下降风险是早期患者的3.4倍。
- 严重体重下降者死亡风险升高(HR=2.37,95%CI 1.77–7.37,p=0.036)。
- 严重体重下降者复发风险呈升高趋势(HR=1.43,95%CI 0.46–3.32,p=0.107)。
关键数值与推荐
- 严重体重下降定义为较基线下降≥10%。
- 严重体重下降与死亡风险的HR=2.37(95%CI 1.77–7.37,p=0.036)。
- 严重体重下降与复发风险的HR=1.43(95%CI 0.46–3.32,p=0.107)。
临床怎么用
- 对局部晚期宫颈癌同步放化疗患者应常规关注体重变化,识别严重体重下降并考虑营养干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine the prevalence, risk factors for, and clinical implications of unintentional weight loss on oncologic outcomes in locally advanced cervical cancer (LACC) treated with concurrent chemotherapy and contemporary radiation techniques. METHODS: This a single-institution, retrospective cohort study of patients with LACC who received definitive chemoradiation (CRT) from 2010 to 2015. Clinicopathologic factors were abstracted by chart review and characterized using descriptive statistics. Factors associated with severe weight loss (≥10% from baseline) were determined by Chi-square test. Time-to-event analysis was performed using the Kaplan Meier method and regression was performed using the Cox Proportional hazards model. RESULTS: One hundred and eight patients comprised the cohort. The majority of patients were White, obese, and had squamous histology. Almost 80% of patients experienced at least some weight loss, with 14% of patients experiencing severe weight loss. Patients with FIGO 2009 stage 3 or 4 disease had a 3.4-fold increased risk of severe weight loss compared to those with earlier stage disease. Patients who had severe weight loss had a higher risk for death (HR = 2.37, 95% confidence interval [CI] 1.77, 7.37, p = 0.036) and a trend toward high risk for recurrence (HR = 1.43, 95% CI 0.46, 3.32, p = 0.107) compared to patients without severe weight loss. CONCLUSION: Unintentional weight loss is a common symptom of patients with LACC receiving CRT that affects oncologic outcomes, yet it remains under-recognized. Increased awareness of weight loss and malnutrition may encourage interventions to improve this potentially modifiable risk factor for worse prognosis and quality of life.
引用
- Jou J, Coulter E, Roberts T, et al. Assessment of malnutrition by unintentional weight loss and its implications on oncologic outcomes in patient with locally advanced cervical cancer receiving primary chemoradiation. Gynecol Oncol. 2020. PMID: 33342621. doi:10.1016/j.ygyno.2020.12.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。